(3S)-1-Benzhydryl-2,2-dimethyl-azetidin-3-ol, 98%, 500mg

(5-Chloro-pyrimidin-2-yl)-cyclopropyl-amine, 95.0%, 5g

4-Bromo-2,6-difluorophenylacetic acid, 95.0%, 250mg

Methyl 4,6-dibromo-3-ethoxy-2-fluorobenzoate, 98%, 1g

2,4,5-Trifluoro-3-methoxybenzoic acid, 98.0%, 500g

(2-(4-Vinylphenyl)ethene-1,1,2-triyl)tribenzene, 97%, 100mg

9-([1,1':3',1''-Terphenyl]-4-yl)-9'-phenyl-9H,9'H-3,3'-bicarbazole, 98%, 250mg

Ethyl 5-bromothiophene-2-carboxylate, 95.0%, 100g

N-Methyl-5-bromo-4,7-diazaindole, 95.0%, 5g

(S)-(1-Benzylpyrrolidin-2-yl)diphenylmethanol, 95.0%, 250mg

rEGCase I assisted by Activator II1vial

1-(5-Aminopyridin-2-yl)ethan-1-one, 97%, 1g

1-[1-(2-methoxyethyl)piperidin-4-yl]-N-methylmethanamine, 95.0%, 5g